Managing central nervous system (CNS) disorders is challenging due to the need for drugs to cross the blood-brain barrier (BBB) and reach the brain. The lipid nature of lipid-based nanocarriers such as SLNs can facilitate the transition across the BBB and translocate them into the brain throu...